Illuminia NextSeq 550 Sequencing System

Sole Source FBO Notice for Procurement Request 000HCCCG-2019-31494
Illumina NextSeq 550 Sequencing System
The Centers for Disease Control and Prevention (CDC) and the National Institute of Occupational Safety and Health (NIOSH), Health Effects Laboratory Division (HELD), Morgantown, WV intends to award a sole source firm fixed price purchase order to Illumina, Inc., 5200 Illumina Way, San Diego, CA 92122-4616 for an Illumina NextSeq 550 Sequencing System if funds become available.
CLIN 0001: Quantity: 1 each.

NexSeq 550

Catalog number SY-415-1002, NextSeq 550 Sequencing System: Illumina NextSeq 550 Sequencing System is an integrated system for automated generation of DNA clonal clusters by bridge amplification, sequencing, primary analysis, and array scanning. System includes embedded touchscreen monitor and on-instrument computer, NextSeq Control Software, installation and training, and 12 months warranty (including parts and labor. Shipping is included in price.

This contract action is for a services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C 3304(a) (1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
The notice of intent is not a request for competitive quotations; however, all quotations/responses received within (15) days of the issuance of this notice will be considered by the Government. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be e-mailed to purchasing agent Rebecca Mullenax at rmullenax@cdc.gov by COB on February 14, 2019.

.